AEE-788
A potent, orally bioavailable dual EGFR/VEGFR receptor tyrosine kinase inhibitor with IC50 of 2, 6, 77 and 59 nM for EGFR, ErbB2, KDR and Flt-1, respectively; inhibits growth factor-induced EGFR and ErbB2 phosphorylation in cells with IC50 of 11 and 220 nM, respectively, demonstrates antiproliferative activity against a range of EGFR and ErbB2-overexpressing cell lines; shows antitumor and antiangiogenic activity in vivo.Brain Cancer Phase 2 Discontinued.
Product Specifications
CAS Number
497839-62-0
Product Name Alternative
AEE 788 | AEE788 | NVP-AEE 788
Purity
>98% (HPLC)
Solubility
DMSO: 10 mM
Smiles
C[C@@H] (NC1=C2C (NC (C3=CC=C (CN4CCN (CC) CC4) C=C3) =C2) =NC=N1) C5=CC=CC=C5
Molecular Formula
C27H32N6
Molecular Weight
440.5832
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
7H-Pyrrolo[2,3-d]pyrimidin-4-amine, 6-[4-[ (4-ethyl-1-piperazinyl) methyl]phenyl]-N-[ (1R) -1-phenylethyl]-
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Cuscuta exaltata Putative membrane protein ycf1 (ycf1), partial
Recombinant Cuscuta exaltata Putative membrane protein ycf1 (ycf1), partial
